The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation
Ibrahim A. Hanouneh, Ariel E. Feldstein, Arthur J. McCullough, Charles Miller, Federico Aucejo, Lisa Yerian, Rocio Lopez, Nizar N. Zein – 28 August 2008 – Although hyperinsulinemia and its associated metabolic syndrome (MS) have been implicated in the progression of hepatic fibrosis in hepatitis C virus (HCV) patients, little is known about the consequences of MS after orthotopic liver transplantation (OLT). The aim of this study was to assess the association between MS and fibrosis progression in patients with recurrent HCV after OLT.